These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29661811)

  • 1. Murine Models of Hepatitis A Virus Infection.
    Hirai-Yuki A; Whitmire JK; Joyce M; Tyrrell DL; Lemon SM
    Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29661811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAVS-dependent host species range and pathogenicity of human hepatitis A virus.
    Hirai-Yuki A; Hensley L; McGivern DR; González-López O; Das A; Feng H; Sun L; Wilson JE; Hu F; Feng Z; Lovell W; Misumi I; Ting JP; Montgomery S; Cullen J; Whitmire JK; Lemon SM
    Science; 2016 Sep; 353(6307):1541-1545. PubMed ID: 27633528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
    Sun L; Feng H; Misumi I; Shirasaki T; Hensley L; González-López O; Shiota I; Chou WC; Ting JP; Cullen JM; Cowley DO; Whitmire JK; Lemon SM
    J Hepatol; 2023 Feb; 78(2):271-280. PubMed ID: 36152761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Hepatocellular Injury in Hepatitis A.
    Wang M; Feng Z
    Viruses; 2021 May; 13(5):. PubMed ID: 34066709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
    Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
    Qu L; Lemon SM
    Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner.
    Sung PS; Hong SH; Lee J; Park SH; Yoon SK; Chung WJ; Shin EC
    Sci Rep; 2017 Jul; 7(1):6387. PubMed ID: 28744018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis.
    Borst K; Frenz T; Spanier J; Tegtmeyer PK; Chhatbar C; Skerra J; Ghita L; Namineni S; Lienenklaus S; Köster M; Heikenwaelder M; Sutter G; Kalinke U
    J Hepatol; 2018 Apr; 68(4):682-690. PubMed ID: 29274730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.
    Proenca-Modena JL; Sesti-Costa R; Pinto AK; Richner JM; Lazear HM; Lucas T; Hyde JL; Diamond MS
    J Virol; 2015 May; 89(9):4720-37. PubMed ID: 25717109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.
    Dutta M; Robertson SJ; Okumura A; Scott DP; Chang J; Weiss JM; Sturdevant GL; Feldmann F; Haddock E; Chiramel AI; Ponia SS; Dougherty JD; Katze MG; Rasmussen AL; Best SM
    Cell Rep; 2017 Jan; 18(3):816-829. PubMed ID: 28099857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
    Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
    J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatovirus 3ABC proteases and evolution of mitochondrial antiviral signaling protein (MAVS).
    Feng H; Sander AL; Moreira-Soto A; Yamane D; Drexler JF; Lemon SM
    J Hepatol; 2019 Jul; 71(1):25-34. PubMed ID: 30876947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
    Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
    PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.
    Wei C; Ni C; Song T; Liu Y; Yang X; Zheng Z; Jia Y; Yuan Y; Guan K; Xu Y; Cheng X; Zhang Y; Yang X; Wang Y; Wen C; Wu Q; Shi W; Zhong H
    J Immunol; 2010 Jul; 185(2):1158-68. PubMed ID: 20554965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells protect against hepatitis A virus infection and limit infection-induced liver injury.
    Misumi I; Mitchell JE; Lund MM; Cullen JM; Lemon SM; Whitmire JK
    J Hepatol; 2021 Dec; 75(6):1323-1334. PubMed ID: 34331968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.